Related references
Note: Only part of the references are listed.Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer
Robin L. Jones et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy
Katja Specht et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer
Christian Parr et al.
EUROPEAN JOURNAL OF CANCER (2009)
Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to Letrozole
William R. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy
Maria Aparecida Azevedo Koike Folgueira et al.
ONCOLOGY REPORTS (2009)
Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer
Renata A. Sobral et al.
ACTA VETERINARIA SCANDINAVICA (2008)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Repression of p53 activity by Smyd2-mediated methylation
Jing Huang et al.
NATURE (2006)
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
Kenneth R. Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients
Sarah Park et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene expression profiling of clinical stages II and III breast cancer
M. A. A. K. Folgueira et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
L Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer
J Hannemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate?
PB Dallas et al.
BMC GENOMICS (2005)
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy
F Bertucci et al.
CANCER RESEARCH (2004)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
JC Chang et al.
LANCET (2003)
Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
JA van der Hage et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
